Boston Partners’s NuVasive, Inc. NUVA Stock Holding History

Boston Partners’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,635	Closed	-$1.75M	–	801
2018 Q2	$1.75M	Buy	+33,635	New	+$1.76M	﹤0.01%	682

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners's NUVA Position: Q3 2018 in Review

Boston Partners sold out of NuVasive, Inc. (NUVA) in Q3 2018, closing a stake of 33,635 shares — an estimated $1.75M sold.

Boston Partners first reported a position in NUVA in Q2 2018 and held it in 1 quarter. The position peaked at $1.75M in Q2 2018. 287 funds tracked by Wall St. Rank hold NUVA as of Q3 2018.

Boston Partners reported no remaining NuVasive, Inc. position as of Q3 2018 after selling out during the quarter.
Boston Partners sold 33,635 NuVasive, Inc. shares in Q3 2018, an estimated $1.75M.
Boston Partners first reported a position in NuVasive, Inc. in Q2 2018 and held it in 1 quarter.
Boston Partners's NuVasive, Inc. position peaked at $1.75M in Q2 2018.
287 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2018.

Based on Boston Partners's 13F filing for Q3 2018, filed 14 Nov 2018.